BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$928M |
| 2 |
Amazon
AMZN
|
+$700M |
| 3 |
Apple
AAPL
|
+$206M |
| 4 |
iShares MSCI Japan ETF
EWJ
|
+$204M |
| 5 |
Tesla
TSLA
|
+$159M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$492M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$407M |
| 4 |
Motorola Solutions
MSI
|
+$327M |
| 5 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$317M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.86% |
| 2 | Consumer Discretionary | 6.24% |
| 3 | Financials | 5.72% |
| 4 | Healthcare | 5.06% |
| 5 | Communication Services | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Washington Trust Bancorp
WASH
$763M
| $415K | ﹤0.01% |
7,357
+2,447
| +50% | +$136K |
|
2952
German American Bancorp
GABC
$1.92B
| $414K | ﹤0.01% |
10,631
+3,737
| +54% | +$150K |
|
2953
Clearwater Paper
CLW
$350M
| $414K | ﹤0.01% |
11,282
-6,499
| -37% | -$259K |
|
2954
Myers Industries
MYE
$1.24B
| $413K | ﹤0.01% |
20,642
-16,297
| -44% | -$330K |
|
|
NPKI
2955
NPK International
NPKI
$1.21B
| $411K | ﹤0.01% |
139,961
+113,188
| +423% | +$363K |
|
2956
Prothena Corp
PRTA
$463M
| $411K | ﹤0.01% |
8,325
+1,571
| +23% | +$87.1K |
|
|
NSTG
2957
DELISTED
NanoString Technologies, Inc.
NSTG
| $408K | ﹤0.01% |
9,664
+1,477
| +18% | +$64.6K |
|
2958
Lexicon Pharmaceuticals
LXRX
$1.03B
| $407K | ﹤0.01% |
103,344
+88,103
| +578% | +$428K |
|
2959
Vitamin Cottage Natural Grocers
NGVC
$645M
| $406K | ﹤0.01% |
28,474
+26,010
| +1,056% | +$333K |
|
2960
Lloyds Banking Group
LYG
$90B
| $405K | ﹤0.01% |
+158,675
| New | +$405K |
|
2961
AllianceBernstein
AB
$3.42B
| $404K | ﹤0.01% |
8,278
+1,867
| +29% | +$97.6K |
|
2962
ING
ING
$102B
| $402K | ﹤0.01% |
28,911
+28,863
| +60,131% | +$419K |
|
|
GTHX
2963
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $402K | ﹤0.01% |
39,383
+31,611
| +407% | +$403K |
|
2964
First Trust Preferred Securities and Income ETF
FPE
$6.34B
| $402K | ﹤0.01% |
+19,772
| New | +$403K |
|
|
PRSU
2965
Pursuit Attractions and Hospitality Inc
PRSU
$1.31B
| $402K | ﹤0.01% |
9,386
-10,450
| -53% | -$477K |
|
|
ATRS
2966
DELISTED
Antares Pharma, Inc.
ATRS
| $401K | ﹤0.01% |
112,212
+82,605
| +279% | +$289K |
|
2967
MasterCraft Boat Holdings
MCFT
$598M
| $400K | ﹤0.01% |
14,124
+10,285
| +268% | +$281K |
|
2968
Invesco DB Agriculture Fund
DBA
$1.24B
| $400K | ﹤0.01% |
+20,246
| New | +$396K |
|
|
TRHC
2969
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $399K | ﹤0.01% |
26,620
+4,529
| +21% | +$82.5K |
|
2970
OraSure Technologies
OSUR
$270M
| $398K | ﹤0.01% |
45,826
-29,765
| -39% | -$294K |
|
|
RYZ
2971
Ryerson Holding Corp
RYZ
$1.5B
| $397K | ﹤0.01% |
15,248
+11,548
| +312% | +$290K |
|
2972
REX American Resources
REX
$1.45B
| $397K | ﹤0.01% |
24,786
-8,952
| -27% | -$137K |
|
2973
Inovio Pharmaceuticals
INO
$110M
| $396K | ﹤0.01% |
6,617
+2,240
| +51% | +$179K |
|
2974
Tootsie Roll Industries
TR
$3.05B
| $395K | ﹤0.01% |
12,645
+8,658
| +217% | +$251K |
|
2975
Orthofix Medical
OFIX
$420M
| $395K | ﹤0.01% |
12,696
-7,773
| -38% | -$260K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2021 Portfolio in Review
As of Q4 2021, BNP Paribas Financial Markets held 4,341 positions worth $70.2B, down 0.46% from $70.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
BNP Paribas Financial Markets withdrew a net $5.34B in Q4 2021, closing 139 positions and reducing 1,467 holdings. Its most notable exit was HILL-ROM HOLDINGS, INC., an estimated $23.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 10% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, BNP Paribas Financial Markets opened a new position in Invesco S&P 500 Equal Weight ETF worth $33M.
- BNP Paribas Financial Markets's largest Q4 2021 buy was Invesco S&P 500 Equal Weight ETF: 202,625 shares worth $33M.
- BNP Paribas Financial Markets added most to Microsoft in Q4 2021, an estimated $928M increase.
- BNP Paribas Financial Markets's biggest Q4 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $1.21B.
- BNP Paribas Financial Markets fully exited HILL-ROM HOLDINGS, INC. in Q4 2021, selling an estimated $23.5M.
- BNP Paribas Financial Markets's ten largest holdings make up 13% of its $70.2B portfolio in Q4 2021.
- BNP Paribas Financial Markets opened 329 new positions and closed 139 in Q4 2021.
- BNP Paribas Financial Markets's portfolio value fell 0.46% quarter-over-quarter to $70.2B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2021, filed 9 Feb 2022.